Payer Support For Express Scripts’ “Transition” From Walgreens Shows Depth Of Interest In Drug Benefit Savings, PBM Says
This article was originally published in The Pink Sheet Daily
During Express Scripts’ earnings call Feb. 23, CEO George Paz said the pharmacy benefit manager’s clients are willing to tolerate the potential inconvenience of a smaller pharmacy network, without Walgreens, because it can save them real money.
You may also be interested in...
The contracting dispute between the drug chain and PBM may also presage tougher negotiations ahead for biopharmaceutical companies, particularly if Express Scripts is successful in its bid to acquire rival PBM Medco.
Following the Federal Trade Commission’s second request for additional information about Express Scripts Inc.'s proposed acquisition of Medco Health Solutions Inc., it is now statistically likely that the deal will be blocked or subject to a divestiture.
Report released as soon-to-be committee chair Ron Wyden, D-OR, assembles plans for drug pricing legislation in the new Democratic-controlled Senate.